Organization · Incubator
Lagunita Biosciences
Lagunita Biosciences is a healthcare investment company and incubator based in Silicon Valley, focused on nurturing early-stage ideas into successful companies.
Overview
What Lagunita Biosciences does
What Lagunita Biosciences is
Lagunita Biosciences is a healthcare investment company and incubator based in Silicon Valley, focused on nurturing early-stage ideas into successful companies.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Incubator
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 7, 2026
What Incubator means
An incubator is a support environment for turning a nascent idea or early company into a startup that is more ready for customers, funding, or an accelerator.
Open the glossary entryOfficial channels
Find Lagunita Biosciences elsewhere
Open the official website or a supported primary organization account.
Capability profile
Lagunita Biosciences as a funder
Investment thesis
Lagunita Biosciences focuses on creating and growing early-stage companies that address significant clinical needs in healthcare.
Focus narrative
Lagunita Biosciences invests in and supports companies in various fields including ophthalmology, oncology, drug discovery, medical devices, and digital health. The organization is committed to addressing significant clinical needs through innovative solutions.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 3
- Recorded notable exits
- Kala Pharmaceuticals, Novartis, and Ligand
Portfolio context
Notable portfolio companies include Kala Pharmaceuticals, acquired in 2021; Novartis, acquired in 2022; and Ligand, acquired in 2020.
Capability profile
Lagunita Biosciences as a program host
Program thesis
Lagunita Biosciences focuses on creating and growing early-stage companies addressing significant clinical needs in healthcare.
Focus narrative
The incubator invests in and supports companies in various healthcare fields, including ophthalmology, oncology, drug discovery, medical devices, and digital health. This diverse focus allows Lagunita to address a wide range of clinical needs and promote advancements in healthcare technology.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Global
Alumni and track record
Alumni context
Notable alumni companies include Kala Pharmaceuticals, acquired in 2021; Novartis, acquired in 2022; and Ligand, acquired in 2020.
Common questions
What to know about Lagunita Biosciences
Upseed classifies Lagunita Biosciences under the Incubator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 7, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.